Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Diluted Average) (2018 - 2025)

Fortress Biotech (FBIO) has 8 years of Shares Outstanding (Diluted Average) data on record, last reported at $29.2 million in Q2 2025.

  • For Q2 2025, Shares Outstanding (Diluted Average) rose 64.53% year-over-year to $29.2 million; the TTM value through Jun 2025 reached $29.2 million, up 64.53%, while the annual FY2024 figure was $20.8 million, 156.25% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $29.2 million in Q2 2025 per FBIO's latest filing, up from $26.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $101.9 million in Q1 2023 and bottomed at $5.9 million in Q3 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $42.6 million, with a median of $23.6 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Diluted Average): plummeted 92.75% in 2022, then soared 162.68% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $81.7 million in 2021, then tumbled by 92.75% to $5.9 million in 2022, then surged by 36.89% to $8.1 million in 2023, then soared by 156.25% to $20.8 million in 2024, then soared by 40.4% to $29.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $29.2 million in Q2 2025, $26.5 million in Q1 2025, and $20.8 million in Q4 2024.